hydroxypumafentrine

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Namehydroxypumafentrine
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPhosphodieterase 4 inhibitorsPhosphodiesterase 3 inhibitors
TargetsPhosphodiesterase 3Phosphodieterase 4
Therapy Area/IndicationsPulmonary Disease, Chronic ObstructiveAsthma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesTakeda GmbH
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTakeda GmbH
Active IndicationsN/A
Inactive IndicationsPulmonary Disease, Chronic ObstructiveAsthma

Other Information

ATC CodeN/A
Related LinksN/A